Company news

Vitrafy Life Sciences Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Q1 FY27 Quarterly Activities Report and Appendix 4C

October 27, 2026

Q1 FY27 Quarterly Activities Report and Appendix 4C

October 27, 2026

Vitrafy enters partnership with Versiti Blood Health

September 29, 2026

S&P DJI Announces September 2026 Quarterly Rebalance

September 4, 2026

Vitrafy enters U.S. Cell & Gene Therapy Market

September 1, 2026

FY26 Full Year Results Presentation

August 3, 2026

FY26 Appendix 4E and Annual Report

August 3, 2026

Q4 FY26 Quarterly Activities Report and Appendix 4C

July 28, 2026

Vitrafy enters a partnership with Hoxworth Blood Center

July 22, 2026

Vitrafy Share Purchase Plan Opens - SPP Offer Booklet

June 18, 2026

Vitrafy Placement Completion and SPP Announcement

June 11, 2026

Vitrafy Equity Raising Presentation

June 11, 2026

Trading Halt

June 9, 2026

Vitrafy enters a partnership with Vitalant Innovation Center

June 1, 2026

Phase 2 USAISR Platelet Results Investor Presentation

May 21, 2026

Final US Army Phase 2 Platelet Results

May 21, 2026

Q3 FY26 Quarterly Activities Report and Appendix 4C

April 27, 2026

USAISR Completes Phase 2 Platelet Study

April 7, 2026

FY26 Half Year Results Presentation

February 3, 2026

FY26 Appendix 4D and Half Year Report

February 3, 2026

Q2 FY26 Quarterly Activities Report and Appendix 4C

January 28, 2026

Vitrafy Enters Strategic Commercial Agreement with IMV

January 14, 2026

IMV Strategic Partnership Investor Presentation

January 14, 2026

Q1 FY26 Quarterly Activities Report and Appendix 4C

October 21, 2025

FY25 Full Year Results Presentation - Amended

August 5, 2025

FY25 Appendix 4E and Annual Report

August 4, 2025

FY25 Full Year Results Presentation

August 4, 2025

Leadership Transition at Vitrafy

August 4, 2025

Q4 FY25 Quarterly Activities Report and Appendix 4C

July 29, 2025

Q3 FY25 Quarterly Activities Report and Appendix 4C

April 28, 2025

USAISR successful Phase 1 Blood Platelet study

April 15, 2025

Vitrafy Awarded Industry Growth Program Grant

March 18, 2025

FY25 Appendix 4D and Half Year Report

February 5, 2025

FY25 Half Year Results Presentation

February 5, 2025

Q2 FY25 Quarterly Activities Report and Appendix 4C

January 30, 2025

Decks

The 5 newest of 18 decks. Every deck is listed under its year.